Healthcare Providers Urge Senate to Oppose Budget Proposal Eliminating 340B Drug Discount Program for Medi-Cal Patients In a press release dated March 22, 2018, the Center For Inherited Blood Disorders has reported that patients with Chronic and debilitating illnesses will suffer under Brown administration proposal to eliminate the 340B Discount Drug Program. Diane J. Nugent, [...]
The National Prescription Drug Take Back Day aims to provide a safe, convenient, and anonymous means of disposing of prescription drugs, while also educating the general public about the potential for abuse and medications. Visit https://takebackday.dea.gov/ to find a location near you.
This month CIBD's staff gathered for a "lunch and learn" built around hemophilia treatments and physical therapy. The presenters were our very own Dr. Amit Soni, Pediatric Hematologist and Associate Medical Director of CIBD, and Grace Hernandez, Physical Therapist at CIBD Clinic. These learning sessions are provided to our diverse team including our CIBD Pharmacy [...]
Saturday, April 29, 2017 10:00 am - 2:00 pm nquiries can also be made at 1-800-882-9539 The National Prescription Drug Take Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse and medications.
"Innovation Belongs In Every Moment" is this year's theme at the Regional Annual Conference. In partnership with the Hemophilia and Thrombosis Treatment Center at Rady Children’s Hospital in San Diego, CIBD co-hosted the 2017 Annual Conference of the Western States Regional Hemophilia Treatment Centers (HTC). Beginning on April 2nd, the two-day conference was held at [...]
It was a sweeping victory for those who support the 21st Century Cures Act, which claims to "modernize and personalize health care, encourage greater innovation, support research, and streamline the system". It would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending (opioids included) [...]